Mesirow Financial Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
21,655
+1,436
+7% +$128K 0.04% 203
2026
Q1
$1.45M Sell
20,219
-197
-1% -$15.2K 0.02% 230
2025
Q4
$1.62M Sell
20,416
-660
-3% -$52K 0.03% 202
2025
Q3
$1.59M Sell
21,076
-614
-3% -$42.1K 0.03% 216
2025
Q2
$1.5M Sell
21,690
-5,991
-22% -$393K 0.03% 221
2025
Q1
$1.88M Sell
27,681
-5,329
-16% -$319K 0.04% 197
2024
Q4
$1.48M Sell
33,010
-95,326
-74% -$5.35M 0.03% 221
2024
Q3
$8.07M Sell
128,336
-20,186
-14% -$1.18M 0.16% 111
2024
Q2
$8.78M Buy
148,522
+1,688
+1% +$106K 0.2% 107
2024
Q1
$11.7M Buy
146,834
+6,213
+4% +$475K 0.27% 90
2023
Q4
$11.1M Buy
+140,621
New +$10M 0.41% 59

Other funds holding CVS

Mesirow Financial Investment Management's CVS Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its CVS Health (CVS) stake by 7.1% in Q2 2026, buying an estimated $128K and bringing the position to 21,655 shares worth $2.24M. The position accounts for 0.04% of the portfolio, ranked #203.

Mesirow Financial Investment Management first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.7M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Mesirow Financial Investment Management held 21,655 shares of CVS Health worth $2.24M as of Q2 2026.
  • Mesirow Financial Investment Management bought 1,436 CVS Health shares in Q2 2026, an estimated $128K.
  • CVS Health made up 0.04% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #203 holding.
  • Mesirow Financial Investment Management first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's CVS Health position peaked at $11.7M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.